牛奶中土霉素残留检测方法改进及临床消除规律探究

试验对牛奶中的土霉素残留检测方法进行了改进,并采用改进后的方法对牛奶中土霉素的临床消除情况进行了探究。样品前处理过程中,选取0.1mol/LNa₂EDTA-Mcllvaine缓冲溶液提取牛奶中的土霉素,正己烷除脂及HLB固相萃取柱净化浓缩。釆用Symmetry Shield RPC18(250mm×4.6mm,5μm)反相色谱柱,以乙腈和0.048%的磷酸溶液(pH2.5)为流动相,采用梯度洗脱的方式对样品进行分析。方法改进后,土霉素的出峰时间为6.5min,峰形尖锐,与样品中的杂质峰分离良好。土霉素标准溶液在5~2000μg/kg范围内线性关系良好,标准曲线R²=0.9999;牛奶中土霉素在10、20、100μg/kg3组浓度的加标回收率分别为87.9%、90.5%和87.8%,批内变异系数范围为2.2%~5.8%,批间变异系数范围为4.0%~5.1%。土霉素在牛奶中的检出限为5μg/kg,定量限为10μg/kg,适用于研究土霉素在牛奶中的残留消除规律。选取了29头产后患有子宫内膜炎的奶牛,分成4个不同剂量组(2、3、4和5g),通过子宫内灌注土霉素的方式进行治疗,然后采用优化后的方法检测牛奶中残留的土霉素。结果发现,4g及以下剂量组给药72h后,牛奶中的土霉素可以消除至残留限量以下;而当给药剂量达到5g时,72h后牛奶中的土霉素未消除至残留限量以下,因此不建议采用5g及以上剂量灌注病牛子宫。

Study on Optimizations of Oxytetracycline Residues Detection Method in Milk and its Clinical Elimination

Here an improved HPLC-PAD method was developed and demonstrated suitable for studying the clinical residue elimination of oxytetracycline in milk from postpartum cows with uterine diseases after intrauterine treatment with oxytetracycline.In this study, 0.1 mol/L Na₂EDTA-Mcllvaine buffer solution was used to extract oxytetracycline from milk, n-hexane for degreasing, and a 3 CC Oasis HLB solid-phase extraction column for purification and concentration.A reversed phase chromatographic column Symmetry Shield RP C18 (250 mm×4.6 mm, 5 μm) with acetonitrile and 0.048% phosphoric acid solution (pH 2.5) as mobile phase by gradient eluting was applied to as the chromatographic separation condition.The results showed that the retention time of oxytetracycline was 6.5 min with a symmetrical and sharp peak, which was well separated from the impurity in the milk sample.Oxytetracycline standard solutions within the concentrations ranging from 5 to 2 000 μg/kg, had a good linearity between peak areas and the concentrations, R²=0.9999.The recoveries of oxytetracycline at three levels of 10, 20, 100 μg/kg were 87.9%, 90.5% and 87.8%, respectively, with the coefficient of variation ranged from 2.2% to 5.8% in intra-day and 4.0% to 5.1% in inter-day.The LOD was 5 μg/kg and the LOQ was 10 μg/kg.All of those parameters suggested that the optimized method was suitable for the study on the clinical residue elimination of oxytetracycline.29 postpartum cows with uterus disease were randomly divided into four different groups in terms of dosage, 2, 3, 4 and 5 g, and treated with oxytetracycline by intrauterine infusion administration, and the residues of oxytetracycline in milk were detected to study its clinical residue elimination.The results showed the oxytetracycline in milk fell to the MRL during 72 h after treatment at 4 g and below dose group.However, in 5 g dose group, residue levels of oxytetracycline in milk were above the MRL at 72 h after treatment.Therefore, 5 g and the higher were not recommended for intrauterine infusion administration.